共 103 条
[1]
Bevan JS(2002)Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size J Clin Endocrinol Metab 87 4554-4563
[2]
Atkin SL(2002)First-line octreotide-LAR therapy induces tumor shrinkage and control hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial Clin Endocrinol 64 342-352
[3]
Atkinson AB(2003)Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results? J Clin Endocrinol Metab 88 3090-3098
[4]
Bouloux PM(2006)Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage J Clin Endocrinol Metab 91 1397-1403
[5]
Hanna F(2007)A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly Clin Endocrinol 66 859-868
[6]
Harris PE(2008)A 12-month, randomized cross-over study on the effects of lanreotide autogel and octreotide long acting repeatable on GH and IGF-1 levels in acromegaly Clin Endocrinol 68 473-480
[7]
Colao A(2010)Rapid and sustained reductions of serum growth hormone and insulin-like growth factor 1 in patients with acromegaly receiving lanreotide autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension Pituitary 13 18-28
[8]
Pivonello R(2013)UK Acromegaly Register Study Group (UKAR-3): control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists Clin Endocrinol 79 689-699
[9]
Rosato F(2004)Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA) Eur J Endocrinol 151 439-446
[10]
Tita P(2013)Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA) Pituitary 16 115-121